Citation Impact
Citing Papers
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
National Incidence and Prevalence of TSH-Secreting Pituitary Adenomas in Sweden
2013
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells
2011 StandoutNobel
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo
2005 Standout
Body mass index in relation to semen quality and reproductive hormonesamong 1,558 Danish men
2004 Standout
Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice
2006 StandoutNobel
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
Energetics, epigenetics, mitochondrial genetics
2009
The Thrombospondins
2011 Standout
Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
2011
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up
2015
Male acquired hypogonadotropic hypogonadism: Diagnosis and treatment
2012
Excess mortality for patients with residual disease following resection of pituitary adenomas
2011
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Extracellular matrix structure
2015 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Methodological quality and synthesis of case series and case reports
2018 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells
2004
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Obesity, lipids, cardiovascular risk, and androgen excess
1995
Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia
2005
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
2011
Obesity and the polycystic ovary syndrome
2002
Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century
2015 Standout
Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma
2007
Polycystic ovary syndrome
2016 Standout
Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity1
1997
Obesity and reproductive disorders in women
2003
Mitochondria and cancer
2012 Standout
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents
2003
Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome
2005
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Primary Medical Treatment of Thyrotropin–Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients
2015
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Thyrotropin-Secreting Pituitary Adenomas: Outcome of Pituitary Surgery and Irradiation
2014
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
2002
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.
1996
Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome1
1997
Genetic Syndromes of Severe Insulin Resistance
2011
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Clinical Features and Management of Non-HIV–Related Lipodystrophy in Children: A Systematic Review
2016
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
1996
Works of B. Delemer being referenced
The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients
2003
Comment interpréter une hypercalcitoninémie ?
2006
Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome
1993
Diagnosis and management of hyperprolactinemia: expert consensus – French Society of Endocrinology
2007
Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism
2007
Fertility and Obstetrical Complications in Women withLMNA-Related Familial Partial Lipodystrophy
2008
Immunohistochemical study of thrombospondin and its receptors alpha root of beta 3 and CD36 in normal thyroid and in thyroid tumours.
1999